Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Kidney International|November 6, 2009
A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatmentLynda A Szczech, Huiman X Barnhart, Shelly Sapp, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremiaJula K Inrig, Shelby D Reed, Lynda A Szczech, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 27, 2017
Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patientsJason A Chou, Elani Streja, Danh V Nguyen, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2007
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patientsJula K Inrig, Uptal D Patel, Barbara S Gillespie, et al.The American Journal of Clinical Nutrition|March 20, 2021
Dietary protein intake, kidney function, and survival in a nationally representative cohortYoko Narasaki, Yusuke Okuda, Linda W Moore, et al.Clinical Journal of the American Society of Nephrology : CJASN|January 2, 2009
Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patientsYanhong Li, Joëlle Y Friedman, Betsy F O'Neal, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremiaMartin E Stryjewski, Lynda A Szczech, Daniel K Benjamin, et al.Journal of the American Society of Nephrology : JASN|April 30, 2016
Overcoming Barriers in Kidney Health-Forging a Platform for InnovationPeter G Linde, Patrick Archdeacon, Matthew D Breyer, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2024
Proteinuria as an End Point in Clinical Trials of Focal Segmental GlomerulosclerosisLaura H Mariani, Howard Trachtman, Aliza Thompson, et al.The New England Journal of Medicine|November 3, 2023
Sparsentan versus Irbesartan in Focal Segmental GlomerulosclerosisMichelle N Rheault, Charles E Alpers, Jonathan Barratt, et al.Pageof 5